Evidence map›Paper›PMID 39468168›Full record

ArticleScientific reports2024

Role of Ti

Rasha A Youness, Mohammed A Taha

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Rasha A YounessSpectroscopy Department, National Research Centre, El Buhouth St, Dokki, Giza, 12622, Egypt. rhakamnrc@gmail.com.
Mohammed A TahaSolid State Physics Department, National Research Centre, El Buhouth St, Dokki, Giza, 12622, Egypt. mtahanrc@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Calcium silicate ceramic is a promising bioceramic for various biomedical applications, but its high biodegradation rate and low strength restrict its clinical utility. As a result, the study devised an innovative solution to address these issues by utilizing the titanium aluminum carbide phase, potentially for the first time in biological applications, in conjugation with hydroxyapatite. Then, using powder metallurgy technology, they added these phases to calcium silicate to create nanocomposites. After soaking in simulated body fluid for ten days, the produced nanocomposites were assessed for bioactivity and biodegradability using scanning electron microscopy, inductively coupled plasma-atomic emission spectroscopy, and weight loss assays. Their electrical and dielectric properties were also measured before and after soaking in the simulated body fluid solution. Furthermore, the tribo-mechanical properties of all sintered samples were measured. Interestingly, adding 40% hydroxyapatite nanoparticles to calcium silicate reduced the porosity from 12 to 6%. However, adding five vol% of the titanium aluminum carbide phase to the same sample increased the porosity to 8%. Importantly, these recorded percentages of porosity were comparable to those of compact bone porosity, which range from 5 to 13%. The addition of hydroxyapatite and titanium aluminum carbide phase significantly improved the rapid biodegradation of calcium silicate, albeit with a slight decrease in its bioactive properties, as evidenced by the incomplete surface coverage of the samples with the hydroxyapatite layer in the scanning electron microscopy images. The electrical properties of the nanocomposites were better with the addition of hydroxyapatite and titanium aluminum carbide phase, which helped the bone heal faster. The addition of a titanium aluminum carbide phase significantly improved the mechanical properties of the resulting nanocomposites. For example, the calculated values for compressive strength of all examined samples were 131, 115, 105, 147, and 135 MPa. Based on the results, the prepared samples can be used in orthopaedic and dental applications.

Indexed as

Calcium CompoundsSilicatesTitaniumBiocompatible MaterialsBone RegenerationCeramicsDurapatiteMaterials TestingMicroscopy, Electron, ScanningNanocompositesPorosityBiocompatible MaterialsCalcium Compoundscalcium silicateDurapatiteSilicatesTitaniumBioactivityBiodegradationBone fracture healing applicationsCalcium silicateElectrical conductivity

Identifiers

PMID39468168
PMCPMC11519508

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.